Amphotericin B lipid complex in the treatment of severe paracoccidioidomycosis: a case series

Highlights • For severe forms of paracoccidioidomycosis (PCM), few therapeutic options are available. • Amphotericin B lipid complex (ABLC) is an option for the treatment of severe PCM. • ABLC is an alternative to amphotericin B deoxycholate.

Saved in:
Bibliographic Details
Published in:International journal of antimicrobial agents 2016-10, Vol.48 (4), p.428-430
Main Authors: Peçanha, Paulo Mendes, de Souza, Stella, Falqueto, Aloísio, Grão-Veloso, Tânia Regina, Lírio, Ludmila Ventura, Ferreira, Carlos Urbano Gonçalves, Santos, Aline Rocha, Costa, Hélbia Garcia, de Souza, Lúcia Renata Meirelles, Tuon, Felipe Francisco
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Amphotericin B
Amphotericin B - administration & dosage
Amphotericin B lipid complex
Antifungal Agents - administration & dosage
Child
Child, Preschool
Female
Humans
Infectious Disease
Liposomal amphotericin B
Male
Middle Aged
Paracoccidioides brasiliensis
Paracoccidioidomycosis
Paracoccidioidomycosis - drug therapy
Retrospective Studies
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • For severe forms of paracoccidioidomycosis (PCM), few therapeutic options are available. • Amphotericin B lipid complex (ABLC) is an option for the treatment of severe PCM. • ABLC is an alternative to amphotericin B deoxycholate.
ISSN:0924-8579
1872-7913
DOI:10.1016/j.ijantimicag.2016.06.011